Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
McKesson
Queensland Health
McKinsey
Merck
Citi
US Army
Medtronic
Healthtrust

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062508

« Back to Dashboard

NDA 062508 describes ERYMAX, which is a drug marketed by Merz Pharms and is included in one NDA. Additional details are available on the ERYMAX profile page.

The generic ingredient in ERYMAX is erythromycin. There are one hundred and two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062508
Tradename:ERYMAX
Applicant:Merz Pharms
Ingredient:erythromycin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 062508

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;TOPICALStrength2%
Approval Date:Jul 11, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Express Scripts
US Department of Justice
Medtronic
QuintilesIMS
Dow
AstraZeneca
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.